![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Exclusive non-clinical data have been selected for presentations at ADA on three of Adocia’s innovative programs: AdoShell®, aimed as a curative treatment for people with Type 1 Diabetes by...
Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French « Code de Commerce » and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers...
Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the...
Regulatory News: Adocia (Euronext Paris : FR0011184241 – ADOC), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solutions thérapeutiques...
Mathieu-William Gilbert, Adocia's new Chief Operating Officer, was previously Vice President and General Manager at Novo Nordisk In his new role, he will oversee Adocia's operations and help...
Mathieu-William Gilbert, nouveau Directeur des Opérations d'Adocia, occupait préalablement des positions de Vice-Présidence et de Direction Générale au sein du laboratoire Novo Nordisk Dans son...
Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the...
Regulatory News: Adocia (Euronext Paris : FR0011184241 – ADOC), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solutions thérapeutiques...
Regulatory News: Conformément aux dispositions de l’article L.233-8 II du Code de Commerce et de l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers (« AMF »). ADOCIA SA...
Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French « Code de Commerce » and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | -8.7 | -75.3246753247 | 11.55 | 11.96 | 2.5 | 23261 | 7.23352665 | CS |
52 | -8.14 | -74.0673339399 | 10.99 | 11.96 | 2.5 | 11165 | 8.59652093 | CS |
156 | -7.2 | -71.6417910448 | 10.05 | 11.96 | 2.5 | 12335 | 9.85882602 | CS |
260 | -7.12 | -71.4142427282 | 9.97 | 11.96 | 2.5 | 19942 | 9.98772927 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions